Cargando…

Lower Performance in Orientation to Time and Place Associates with Greater Risk of Cardiovascular Events and Mortality in the Oldest Old: Leiden 85-Plus Study

Background: Impairment in orientation to time and place is commonly observed in community-dwelling older individuals. Nevertheless, the clinical significance of this has been not fully explored. In this study, we investigated the link between performance in orientation domains and future risk of car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rostamian, Somayeh, van Buchem, Mark A., Jukema, J. Wouter, Gussekloo, Jacobijn, Poortvliet, Rosalinde K. E., de Cren, Anton J. M., Sabayan, Behnam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623724/ https://www.ncbi.nlm.nih.gov/pubmed/29021754 http://dx.doi.org/10.3389/fnagi.2017.00307

Ejemplares similares

Disability transitions in the oldest old in the general population. The Leiden 85-plus study
por: van Houwelingen, Anne H., et al.
Publicado: (2013)

Clinical determinants of low handgrip strength and its decline in the oldest old: the Leiden 85-plus Study
por: Ling, Carolina H. Y., et al.
Publicado: (2020)

The effect of cognitive impairment on the predictive value of multimorbidity for the increase in disability in the oldest old: the Leiden 85-plus Study
por: Drewes, Yvonne M., et al.
Publicado: (2011)

Prognostic value of cardiovascular disease status: the Leiden 85-plus study
por: van Peet, Petra G., et al.
Publicado: (2012)

Clinically diagnosed infections predict disability in activities of daily living among the oldest-old in the general population: the Leiden 85-plus Study
por: Caljouw, Monique A. A., et al.
Publicado: (2013)

Prediction of mortality and functional decline by changes in eGFR in the very elderly: the Leiden 85-plus study
por: Van Pottelbergh, Gijs, et al.
Publicado: (2013)

NT-proBNP Best Predictor of Cardiovascular Events and Cardiovascular Mortality in Secondary Prevention in Very Old Age: The Leiden 85-Plus Study
por: van Peet, Petra G., et al.
Publicado: (2013)

Visual impairment as a predictor for deterioration in functioning: the Leiden 85-plus Study
por: Verbeek, ERJ, et al.
Publicado: (2022)

Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study
por: Chen, Sijia, et al.
Publicado: (2012)

Impact of valvular heart disease on activities of daily living of nonagenarians: the leiden 85-plus study a population based study
por: van Bemmel, Thomas, et al.
Publicado: (2010)

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018)

Predictive Value of a Profile of Routine Blood Measurements on Mortality in Older Persons in the General Population: The Leiden 85-Plus Study
por: van Houwelingen, Anne H., et al.
Publicado: (2013)

Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies
por: Rostamian, Somayeh, et al.
Publicado: (2022)

Correction: Predictive Value of a Profile of Routine Blood Measurements on Mortality in Older Persons in the General Population: The Leiden 85-Plus Study
por: van Houwelingen, Anne H., et al.
Publicado: (2015)

Assessment of Appropriateness of Cardiovascular Preventive Medication in Adults ≥ 75 years
por: van der Ploeg, Milly, et al.
Publicado: (2020)

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
por: Rozsnyai, Zsofia, et al.
Publicado: (2020)

Effects of discontinuation of levothyroxine treatment in older adults: protocol for a self-controlled trial
por: Ravensberg, A Janneke, et al.
Publicado: (2023)

Managing hypertension in frail oldest-old—The role of guideline use by general practitioners from 29 countries
por: Roulet, Céline, et al.
Publicado: (2020)

Systematic Review of Guidelines on Antihypertensive Treatment in Older Adults: SPRINTing to More Heterogeneity?
por: Bogaerts, Jonathan, et al.
Publicado: (2020)

Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method
por: van der Ploeg, Milly A., et al.
Publicado: (2022)

Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Poortvliet, Rosalinde K. E., et al.
Publicado: (2012)

Predictive factors of urinary tract infections among the oldest old in the general population. a population-based prospective follow-up study
por: Caljouw, Monique AA, et al.
Publicado: (2011)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study
por: Vaes, Bert, et al.
Publicado: (2020)

Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk
por: Drewes, Yvonne M, et al.
Publicado: (2014)

Engaging the oldest old in research: lessons from the Newcastle 85+ study
por: Davies, Karen, et al.
Publicado: (2010)

Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study
por: van der Ploeg, Milly A., et al.
Publicado: (2016)

Correction: Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study
por: van der Ploeg, Milly A., et al.
Publicado: (2021)

Intracerebral Hemorrhage in the Oldest Old: A Population-Based Study (Vantaa 85+)
por: Tanskanen, Maarit, et al.
Publicado: (2012)

Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study
por: Hall, Anette, et al.
Publicado: (2019)

Genes Involved in DNA Damage Cell Pathways and Health of the Oldest-Old (85+)
por: Šetinc, Maja, et al.
Publicado: (2023)

Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases
por: Bogaerts, Jonathan M K, et al.
Publicado: (2021)

Patterns and predictors of place of cancer death for the oldest old
por: Lock, Anna, et al.
Publicado: (2005)

Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines
por: van der Ploeg, Milly A., et al.
Publicado: (2019)

Burden of cardiovascular disease across 29 countries and GPs’ decision to treat hypertension in oldest-old
por: Streit, Sven, et al.
Publicado: (2018)

Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries
por: Streit, Sven, et al.
Publicado: (2017)

Total Joint Replacement in the Past Does Not Relate to a Deteriorated Functional Level and Health Status in the Oldest Old
por: Verra, Wiebe Chr., et al.
Publicado: (2012)

Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice
por: Pouwer, Marianne G, et al.
Publicado: (2019)

Primary age‐related tauopathy in a Finnish population‐based study of the oldest old (Vantaa 85+)
por: Savola, Sara, et al.
Publicado: (2022)

The Leiden Convention coronary coding system: translation from the surgical to the universal view
por: Koppel, Claire J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i55het9lfu3ce3101ebuq9ijqe